文献速递精神分裂症与精神病性障碍

难治性精神分裂症的代谢生物标志物与认知关联:机器学习研究

Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning.
PubMed 文献 · Mol Psychiatry · 2026-08-19

本研究纳入112例难治性精神分裂症(TRS)患者、232例非TRS患者和145例性别年龄匹配的健康对照,采用UHPLC-HRMS定量699种代谢物,结合随机森林算法和5×5嵌套交叉验证构建TRS识别模型。模型合并的折外AUC为0.958(95%CI 0.940-0.977),并发现前五位预测代谢物与TRS和非TRS患者认知域存在不同关联。

要点

  • 基于699种代谢物的随机森林模型对TRS分类的合并折外AUC达0.958(95%CI 0.940-0.977)。
  • 58种代谢物在TRS中显著改变(VIP>1.5,FDR p<0.05)。
  • γ-谷氨酰苏氨酸与TRS患者视空间认知负相关(r=-0.25,p=0.009),非TRS中正相关(r=0.16,p=0.015),但FDR校正后不显著。

核心结论

  • 研究建立了基于随机森林的代谢组学模型用于识别难治性精神分裂症,并揭示了与认知功能障碍相关的特定代谢特征。

研究设计与样本

  • 研究纳入112例TRS患者、232例非TRS患者和145例性别年龄匹配的健康对照,采集空腹血样用UHPLC-HRMS定量699种代谢物,采用OPLS-DA和随机森林算法建模,并通过5×5嵌套交叉验证(内循环LASSO特征选择)验证。

主要发现

  • 从699种代谢物中筛选出58种显著改变(VIP>1.5,FDR p<0.05)。
  • 5×5嵌套交叉验证结合内循环LASSO特征选择的模型对TRS分类的合并折外AUC为0.958(95%CI 0.940-0.977)。
  • γ-谷氨酰苏氨酸与TRS患者视空间认知显著负相关(r=-0.25,p=0.009),在非TRS组呈正相关(r=0.16,p=0.015),但FDR校正后关联不显著。

关键数值与推荐

  • TRS分类模型性能:合并折外AUC 0.958(95%CI 0.940-0.977)。
  • 代谢物显著改变标准:VIP>1.5且FDR p<0.05,共58种代谢物满足。
  • γ-谷氨酰苏氨酸与视空间认知的相关系数:TRS组r=-0.25(p=0.009),非TRS组r=0.16(p=0.015)。

临床怎么用

  • 代谢组学联合机器学习模型有望辅助TRS的早期识别,但需外部验证。
  • 特定代谢物与认知域的关联提示代谢改变可能参与TRS认知功能障碍,但关联经FDR校正后不显著,暂不宜作为临床诊断依据。

局限性

  • 代谢物与认知的关联经FDR校正后未保持显著。
  • 模型性能基于嵌套交叉验证的折外预测,尚未在独立外部样本中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early identification of Treatment-resistant schizophrenia (TRS) remains a challenge. Metabolomics offers a promising strategy for identifying biomarkers and uncovering the metabolic alterations underlying TRS. Machine learning (ML), increasingly applied in omics research, enables the development of predictive models from complex datasets. This study aimed to develop a metabolomics-based ML model for TRS identification and to examine its association with cognitive impairments. 112 TRS patients, 232 non-TRS patients, and 145 sex- and age-matched healthy controls were recruited in this study. Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive function was evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Toronto Alexithymia Scale (TAS-26). Fasting blood samples were collected from all participants and analyzed by UHPLC-HRMS, enabling the quantification and profiling of 699 metabolites. The resulting data were then subjected to orthogonal partial least squares discriminant analysis (OPLS-DA), and a predictive model was constructed using a random forest algorithm, which was validated through 5 × 5 nested cross-validation with inner-loop LASSO feature selection. From 699 metabolites, 58 metabolites exhibited significant changes (VIP > 1.5, FDR p < 0.05). 5 × 5 nested cross-validation combining an inner-loop LASSO feature selection model yielded a pooled out-of-fold AUC of 0.958 (95% CI (DeLong): 0.940-0.977) for TRS classification. Further correlation analyses revealed distinct associations between the top five predictive metabolites and cognitive domains in TRS versus non-TRS patients. Gamma-glutamylthreonine (gamma-Glu-Thr) showed a significant negative correlation with visuospatial cognition in TRS patients (r = -0.25, p = 0.009). In contrast, it showed a positive correlation in the non-TRS group (r = 0.16, p = 0.015). However, these associations did not remain significant after FDR correction. This study established an RF-metabolomic model for identifying TRS and provided specific metabolic signatures associated with cognitive dysfunction.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang C, Dong Y, Li T, et al. Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning. Mol Psychiatry. 2026. PMID: 42618603. doi:10.1038/s41380-026-03827-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。